- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06198699
Effects of Jing Si Herbal Tea on Quality of Life and Sleep in Dementia and Their Caregivers
April 7, 2026 updated by: Chung-Ying Lin, National Cheng Kung University
Effects of Jing Si Herbal Tea on Quality of Life and Sleep Among Patients With Dementia and Their Caregivers: A Randomized Controlled Trial
Jing Si Herbal Tea has been found to be effective in improving health for the conditions of cancers, aging, depression, and sleep.
Such evidence has been shown in animal models and clinical research with publications in the international journals.
However, empirical evidence regarding the effectiveness of Jing Si Herbal Tea for patients with dementia and their caregivers on their quality of life and psychosocial health remains unclear.
Therefore, the present project aims to investigate the feasibility of taking Jing Si Herbal Tea among patients with dementia; then, to investigate if Jing Si Herbal Tea could improve quality of life and psychosocial health for patients with dementia and their caregivers.
The project will be three years.
The first year will examine the feasibility for the patients with dementia.
A total of 100 patients with dementia will be recruited and they will be informed to take the Jing Si Herbal Tea two times per day (one time in the morning and another time in the afternoon).
All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to have initial evidence of the improvements in quality of life and psychosocial health without having a control group.
The second year will recruit 200 patients with dementia and randomly assign them into a treatment group (taking Jing Si Herbal Tea) and a control group (taking placebo).
All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to investigate the strong evidence of Jing Si Herbal Tea on quality of life and psychosocial health.
The third year will recruit 200 caregivers of patient with dementia and randomly assign them into a treatment group (taking Jing Si Herbal Tea) and a control group (taking placebo).
All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to investigate the strong evidence of Jing Si Herbal Tea on quality of life and psychosocial health.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chung-Ying Lin, PhD
- Phone Number: 5106 +886-2353535
- Email: cylin36933@gs.ncku.edu.tw
Study Locations
-
-
-
Hualien City, Taiwan
- Recruiting
- Tzu-Chi General Hospital
-
Contact:
- Hao-Ming Li, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
For people with dementia:
Inclusion Criteria:
- diagnosis of dementia
- 50 years or older
- with sufficient cognition to complete the questionnaires
- can communicate using Mandarin or Taiwanese
Exclusion Criteria:
- with renal function problems
- not suitable for Jing Si Herbal Tea after evaluation from a psychiatrist/physician
- with the condition of change the commencement of guardianship (or commencement of assistance)
For caregivers:
Inclusion Criteria:
- caregivers of people with dementia for more than half years
- 20 years or older
- with sufficient cognition to complete the questionnaires
- can communicate using Mandarin or Taiwanese
Exclusion Criteria:
- with renal function problems
- not suitable for Jing Si Herbal Tea after evaluation from a psychiatrist/physician
- with the condition of change the commencement of guardianship (or commencement of assistance)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Jing Si Herbal Tea Group
Frequency: Two times of herbal tea (one in the morning; one in the afternoon) per day Duration: Consumption for three months Dosage: One pack (14g) with 600 ml water for each time of herbal tea consumption
|
Consuming Jing Si Herbal Tea for three months; twice per day with each time 14 g of Jing Si Herbal in 600 ml water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
World Health Organization Quality of Life Assessment for age (WHOQOL-AGE) [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
quality of life measure; score range 13-65; higher score indicates better quality of life
|
baseline; 3 months after baseline; 6 months after baseline
|
|
Insomnia Severity Index [for both people with dementia and their caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
sleep problem measure; score range 0-28; higher score indicates more severe insomnia
|
baseline; 3 months after baseline; 6 months after baseline
|
|
World Health Organization Quality of Life Assessment brief version (WHOQOL-BREF) [for caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
quality of life measure; score range 4-20; higher score indicates better quality of life
|
baseline; 3 months after baseline; 6 months after baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Katz Index of Independence in Activities of Daily Living [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
activities of daily living function measure; score range 0-6; higher score indicates better activities of daily living
|
baseline; 3 months after baseline; 6 months after baseline
|
|
5 items of Geriatric Depression Scale [for people with dementia and their caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
depression measure; score range 0-5; higher score indicates greater depression
|
baseline; 3 months after baseline; 6 months after baseline
|
|
Short Portable Mental Status Questionnaire [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
cognition measure; score range 0-10; higher score indicates poor cognition
|
baseline; 3 months after baseline; 6 months after baseline
|
|
Clinical Frailty Scale [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
frailty measure; score range 1-9; higher score indicates more frail
|
baseline; 3 months after baseline; 6 months after baseline
|
|
Integrated care for older people [for people with dementia]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
intrinsic capacity measure; score range 0-13; higher score indicates poorer intrinsic capacity
|
baseline; 3 months after baseline; 6 months after baseline
|
|
Attitude and Thoughts Toward Older People Scale [for people with dementia and their caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
ageism measure; score range 17-85; higher score indicates higher level of ageism
|
baseline; 3 months after baseline; 6 months after baseline
|
|
Depression, Anxiety, Stress Scale-21 [for people with dementia and their caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
psychological distress measure; score range 0-63; higher score indicates greater distress
|
baseline; 3 months after baseline; 6 months after baseline
|
|
12 item of Zarit Burden Interview [for caregivers]
Time Frame: baseline; 3 months after baseline; 6 months after baseline
|
caregiver burden measure; score range 0-48; higher score indicates greater burden
|
baseline; 3 months after baseline; 6 months after baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comorbidity
Time Frame: baseline
|
Other chronic disease the participants have
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hao-Ming Li, MD, Buddhist Tzu Chi General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 17, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
December 27, 2023
First Submitted That Met QC Criteria
December 27, 2023
First Posted (Actual)
January 10, 2024
Study Record Updates
Last Update Posted (Actual)
April 13, 2026
Last Update Submitted That Met QC Criteria
April 7, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- TCMF-JCT 113-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
Clinical Trials on Jing Si Herbal Tea
-
Taichung Tzu Chi HospitalCompletedNon-alcoholic Fatty Liver DiseaseTaiwan
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Not yet recruitingChronic Pelvic Pain Syndrome (CPPS)Taiwan
-
Buddhist Tzu Chi General HospitalCompletedIrritable Bowel Syndrome | Functional Gastrointestinal Disorders | Healthy Subjects | COVID-19 PneumoniaTaiwan
-
Buddhist Tzu Chi General HospitalCompletedFunctional Gastrointestinal Disorders | Healthy SubjectsTaiwan
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Completed
-
Buddhist Tzu Chi General HospitalNot yet recruitingCardiovascular Diseases | Inflammatory Response | Gut Microbiome | Herbal Medicine | Life Quality | Trimethylamine N-oxide
-
Buddhist Tzu Chi General HospitalActive, not recruitingAtherosclerosis | Gut Microbiome | Trimethylamine N-oxide | HbA1c | Inflammatory MarkerTaiwan
-
Buddhist Tzu Chi General HospitalRecruitingDLQI | PHQ-9 | PSAI | Serum Cytokine SurveyTaiwan
-
Buddhist Tzu Chi General HospitalEnrolling by invitationFatigue | Arthritis | Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing SpondylitisTaiwan
-
Yao-Kuang WuRecruiting